Home
About Us
About MEDTL
MEDTL Medical Technologies Ltd. is dedicated to providing innovative medical devices and AI-driven healthcare solutions to improve patient outcomes worldwide.
Company Overview
Board of Directors
The Board of Directors of MEDTL Medical Technologies Ltd. provides strategic leadership and governance
to advance the company’s mission of revolutionizing cardiovascular care through the application of
artificial intelligence.
Comprising accomplished professionals with extensive experience in healthcare, technology, and business
management, the Board oversees MEDTL’s long-term vision, operational excellence, and adherence to the
highest ethical and regulatory standards. Guided by a shared commitment to innovation and patient
well-being, the Board ensures that MEDTL’s AI-powered solutions contribute meaningfully to preventive,
accurate, and accessible cardiovascular diagnostics worldwide.
Dinos Matheou
Founder & Managing Director
Joseph Borghese
Entrepreneur & Philanthropist
Louis Antoniou
Executive & Global Markets Leader
Dr. Panayiotis Philimis
Innovation & Deep-Tech Advisor
Dr. Artemis Kontou
Research & Innovation Advisor
Advisory Committee
The Advisory Committee at MEDTL Medical Technologies Ltd. comprises highly experienced medical cardiologists who contribute specialized clinical expertise to the design, validation, and evaluation of MEDTL’s technologies. Their involvement ensures that all research and development activities are grounded in current clinical practices and evidence-based methodologies. Through continuous collaboration, the Committee provides critical oversight in areas such as diagnostic accuracy, clinical relevance, and patient safety, thereby supporting MEDTL’s commitment to advancing AI-driven cardiovascular diagnostics that meet rigorous medical and regulatory standards.
Dr. Constantinos Markides
Medical Advisor
Dr. Petros Petrou
Senior Medical Advisor
Dr. Sotiris Attipas
Medical Consultant
Dr. Stelios Hadjistylis
Strategy Advisor
Dr. Aspasia Thanasia
Senior Consultant